Funding for this research was provided by:
Agency for Healthcare Research and Quality (R01HS025386)
Pearl J. Aldrich Endowment in Aging Related Research
Clinical and Translational Sciences Institute, Michigan State University
Received: 30 September 2020
Accepted: 14 May 2021
First Online: 26 May 2021
: All methods were conducted in accordance with approvals granted by the Michigan State University IRB under the number × 17-922eD (Experiment 1) and Michigan State Univeristy Psychology and Social Science Internal Review Board STUDY00000832 (Experiment 2).
: All authors have provided significant contributions to this effort, have had the opportunity to contribute to this draft and provided approvals of the same.
: LB has served as a consultant to Vertex Pharmaceuticals, Inc., a biotech firm focused on drugs to treat cystic fibrosis, providing expertise on the development of protocols to evaluate packaging ease of use. LB has received an honorarium and travel reimbursement to speak at Baxter and Johnson & Johnson Companies and travel reimbursement to share work from her group at the International Quality and Productivity Center’s conference on Pharmaceutical Labeling. Travel reimbursement has also been provided by the US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC) in support of her participation for ongoing efforts medication safety. LL’s work which also investigated OTC labeling strategies, was funded by the Consumer Healthcare Products Association (CHPA) and MWB and LB were co-PIs for these funds. None of these entities played any role in the design or conduct of the study; collection, management, analysis or interpretation of the date; preparation, review or approval of the manuscript or the decision to submit or publish the study.